36 related articles for article (PubMed ID: 8256733)
1. Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia.
Sato S; Zamami Y; Imai T; Tanaka S; Koyama T; Niimura T; Chuma M; Koga T; Takechi K; Kurata Y; Kondo Y; Izawa-Ishizawa Y; Sendo T; Nakura H; Ishizawa K
Sci Rep; 2017 Oct; 7(1):12683. PubMed ID: 28978927
[TBL] [Abstract][Full Text] [Related]
2. Neuromodulation for the Treatment of Refractory Ventricular Arrhythmias.
Markman TM; Gugger D; Arkles J; Riley MP; Dixit S; Guandalini GS; Frankel DS; Epstein AE; Callans DJ; Singhal S; Marchlinski FE; Nazarian S
JACC Clin Electrophysiol; 2023 Feb; 9(2):161-169. PubMed ID: 36858681
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring of antiarrhythmic drugs.
Jürgens G; Graudal NA; Kampmann JP
Clin Pharmacokinet; 2003; 42(7):647-63. PubMed ID: 12844326
[TBL] [Abstract][Full Text] [Related]
4. Effects of amiodarone on cardiac function and mitochondrial oxidative phosphorylation during ischemia and reperfusion.
Moreau D; Clauw F; Martine L; Grynberg A; Rochette L; Demaison L
Mol Cell Biochem; 1999 Apr; 194(1-2):291-300. PubMed ID: 10391152
[TBL] [Abstract][Full Text] [Related]
5. Intravenous amiodarone for the rapid treatment of life-threatening ventricular arrhythmias in critically ill patients with coronary artery disease.
Ochi RP; Goldenberg IF; Almquist A; Pritzker M; Milstein S; Pedersen W; Gobel FL; Benditt DG
Am J Cardiol; 1989 Sep; 64(10):599-603. PubMed ID: 2782249
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia.
Kalbfleisch SJ; Williamson B; Man KC; Vorperian V; Hummel JD; Hasse C; Strickberger SA; Calkins H; Langberg JJ; Morady F
J Am Coll Cardiol; 1993 Nov; 22(6):1723-9. PubMed ID: 8227846
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
[TBL] [Abstract][Full Text] [Related]
9. Oral amiodarone loading for the rapid treatment of frequent, refractory, sustained ventricular arrhythmias associated with coronary artery disease.
Russo AM; Beauregard LM; Waxman HL
Am J Cardiol; 1993 Dec; 72(18):1395-9. PubMed ID: 8256733
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.
Van Herendael H; Dorian P
Vasc Health Risk Manag; 2010 Aug; 6():465-72. PubMed ID: 20730062
[TBL] [Abstract][Full Text] [Related]
11. Parenteral antiarrhythmic drug therapy in ventricular tachycardia/ventricular fibrillation: evolving role of class III agents--focus on amiodarone.
Scheinman MM
J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):914-9. PubMed ID: 8548112
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
